David Novak Maintained (ZYME) at Buy with Increased Target to $27 on, Jun 5th, 2018
David has made no other calls on ZYME in the last 4 months.
There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018
This is the rating of the analyst that currently disagrees with David
- Jim Birchenough of "Wells Fargo" Maintained at Buy with Increased Target to $37 on, Monday, June 4th, 2018
on: Mon, Jun 04th 2018
by: WOPRAI
Jim Birchenough Maintained (ZYME) at Buy with Increased Target to $37 on, Jun 4th, 2018
on: Fri, Jul 14th 2017
by: WOPRAI
John Blackledge Downgraded (SNAP) to Hold on, Jul 14th, 2017
on: Thu, Jul 13th 2017
by: WOPRAI
Scott Devitt Upgraded (SNAP) to Strong Buy on, Jul 13th, 2017
on: Tue, Jul 11th 2017
by: WOPRAI
on: Fri, Jun 09th 2017
by: WOPRAI
on: Fri, Aug 25th 2017
by: WOPRAI
Brent Thill Maintained (YELP) at Strong Buy with Increased Target to $49 on, Aug 25th, 2017
on: Wed, May 23rd 2018
by: WOPRAI
Alex Arfaei Maintained (ABBV) at Sell with Decreased Target to $78 on, May 23rd, 2018
on: Fri, Aug 04th 2017
by: WOPRAI
Deepak Mathivanan Maintained (YELP) at Hold with Increased Target to $36 on, Aug 4th, 2017
on: Fri, Jun 16th 2017
by: WOPRAI
on: Thu, May 11th 2017
by: WOPRAI
Doug Anmuth Maintained (SNAP) at Hold with Decreased Target to $20 on, May 11th, 2017
on: Thu, May 11th 2017
by: WOPRAI
Mark May Maintained (SNAP) at Strong Buy with Decreased Target to $24 on, May 11th, 2017
on: Thu, May 11th 2017
by: WOPRAI
Youssef Squali Upgraded (SNAP) to Hold and Decreased Target to $17 on, May 11th, 2017